Tiago Biachi de Castria, MD, PhD, associate member in the Department of Gastrointestinal Oncology at Moffitt Cancer Center, discusses how precision medicine tools have aided oncologists in treating patients with solid tumors, while reducing overall toxicity.
Precision medicine allows oncologists to have a better understanding of tumor type, behavior, and mechanism resistance, to provide a patient with the right treatment at the right time, says Tiago Biachi de Castria, MD, PhD, associate member in the Department of Gastrointestinal Oncology at Moffitt Cancer Center.
He presented on the topic of “Precision Medicine Developments in Solid Tumors" at our recent Institute for Value-Based Medicine® event in Tampa, Florida.
Transcript
Can you provide an overview of what your topic was about on the significance of precision medicine in solid tumors?
Of course. So, in other words, this is precision oncology; this is a fascinating topic. We're doing a great job, and this is about tumor categorization. So now, we were able to define not only gene sequencing, but we were able to go deeper and analyze tumor RNA expression, protein expression, metabolism, profile of methylation, and microbiomes. By doing that, we have a better sense of what kind of a tumor, tumor behavior, and mechanism resistance. And by doing that, we can offer the right treatment for the right patient at the right time.
What were some of the methods and key metrics used to assess your findings?
I might be biased because I'm a GI [gastrointestinal] medical oncologist, but I used in my presentation a couple examples in colorectal cancer, for example, which is one of my fields that I'm more focused on here at Moffitt. And I used a couple of trials to show how we could translate precision oncology with all these methods in the better treatments and consequently, in better outcomes to our patients. And we discussed about how we can implement precision oncology in more trial designs to try to expedite drug development in oncology.
Housing Assistance May Help Renters With Cancer Better Withstand Medical Financial Strain
August 28th 2025Housing assistance significantly reduces medical financial hardship for renters with a history of cancer, enhancing their financial security and access to care amid rising health costs.
Read More
Infertility Coverage Boosts ART Use and Pregnancy Success: Richard A. Brook, MS, MBA
August 26th 2025In this episode, Richard A. Brook, MS, MBA, discusses his study showing that infertility treatment coverage increases assisted reproductive technology (ART) use and improves pregnancy outcomes.
Listen
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen
For Better Cancer Outcomes, It’s All About Access
August 21st 2025New drugs aren't the only advances in oncology. Innovation includes collaboration between to remove barriers to remove barriers to care, according to experts who gathered for a session of the Institute for Value-Based Medicine in Arlington, Virginia.
Read More
Building Accountability Into GLP-1 Benefit Design: Lessons From Delaware and Philadelphia
August 20th 2025Employers explore glucagon-like peptide-1 (GLP-1) therapies' impact on health benefits, showcasing accountability and data-driven strategies in Philadelphia, Pennsylvania, and Wilmington, Delaware, for sustainable health programs.
Read More